SCHEMBL7364879

SCHEMBL7364879

COc1ccc(CNC(=O)c2cc(C(F)(F)F)ccc2N(CN)CCO)cc1Cl

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 13/20 0.47
PPARG P37231 4/20 0.47
PPARD Q03181 4/20 0.47
GAA P10253 1/20 0.44
LMNA P02545 1/20 0.44
PDE5A O76074 3/20 0.43
PSEN1 P49768 3/20 0.43
PSEN2 P49810 3/20 0.43
APH1B Q8WW43 3/20 0.43
NCSTN Q92542 3/20 0.43
APH1A Q96BI3 3/20 0.43
PSENEN Q9NZ42 3/20 0.43
PDE6D O43924 1/20 0.43
PDE6A P16499 1/20 0.43
PDE6G P18545 1/20 0.43
PDE6B P35913 1/20 0.43
PDE6C P51160 1/20 0.43
PDE6H Q13956 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7367480 0.90 PPARA (0.47) PPARAPPARGPPARDGAALMNA
SCHEMBL7362850 0.88 PPARA (0.44) PPARAPPARGPPARDGAALMNA
SCHEMBL7361367 0.81 PPARA (0.42) PPARAPPARGPPARDGAALMNA
SCHEMBL6943273 0.80 PPARA (0.55) PPARAPPARGPPARDGAALMNA
SCHEMBL7361602 0.80 PPARA (0.48) PPARAPPARGPPARDLMNAPSEN1
SCHEMBL7372290 0.78 PPARA (0.53) PPARAPPARGPPARDGAAPDE5A
SCHEMBL6941879 0.76 PPARA (0.52) PPARAPPARGPPARDGAAPDE5A
SCHEMBL7391649 0.76 PDE5A (0.46) GAALMNAPDE5A
SCHEMBL7368682 0.76 TSHR (0.45) LMNA
Hydrochloric Acid SCHEMBL7361883 0.75 TSHR (0.45) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001030745-A1 ANTHRANILIC ACID DERIVATIVES AS INHIBITORS OF THE CGMP-PHOSPHODIESTERASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-05-03 WO disclosed
US-5652237-A 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes WARNER-LAMBERT COMPANY (US) 1997-07-29 US disclosed
WO-1996007648-A1 2-SUBSTITUTED-4H-3,1-BENZOXAZIN-4-ONES AND BENZTHIAZIN-4-ONES AS INHIBITORS OF COMPLEMENT Clr PROTEASE FOR THE TREATMENT OF INFLAMMATORY PROCESSES WARNER-LAMBERT COMPANY (US) 1996-03-14 WO disclosed